Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEton Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.03 | $0.19 | $0.11 |
| Q2 2026 | 2 | $0.15 | $0.22 | $0.19 |
| Q3 2026 | 2 | $0.36 | $0.40 | $0.38 |
| Q4 2026 | 2 | $0.28 | $0.58 | $0.44 |
| Q1 2027 | 1 | $0.44 | $0.47 | $0.46 |
| Q2 2027 | 1 | $0.50 | $0.54 | $0.52 |
| Q3 2027 | 1 | $0.55 | $0.59 | $0.57 |
| Q4 2027 | 1 | $0.60 | $0.64 | $0.62 |
| Q1 2028 | 1 | $0.62 | $0.66 | $0.64 |
| Q2 2028 | 1 | $0.67 | $0.71 | $0.69 |
| Q3 2028 | 1 | $0.74 | $0.78 | $0.76 |
| Q4 2028 | 1 | $0.81 | $0.87 | $0.84 |
Eton Pharmaceuticals Inc Earnings Date And Information
Eton Pharmaceuticals Inc last posted its earnings results on Thursday, August 13th, 2026. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.1898 by $0.2402. The company had revenue of 37.59 M for the quarter and had revenue of 79.95 M for the year. Eton Pharmaceuticals Inc has generated $0 earnings per share over the last year ($-0.17 diluted earnings per share) and currently has a price-to-earnings ratio of 136.49. Eton Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Eton Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | $0.19 | $0.42 | 0.23 | $27.11 M | $37.59 M |
| 05/14/2026 | Q1 2026 | $0.10 | $0.06 | -0.04 | $22.31 M | $24.27 M |
| 03/19/2026 | Q4 2025 | $0.12 | $0.06 | -0.07 | $19.98 M | $21.28 M |
| 11/06/2025 | Q3 2025 | $0.16 | -$0.07 | -0.23 | $20.46 M | $22.46 M |
| 08/07/2025 | Q2 2025 | -$0.01 | -$0.10 | -0.09 | $16.71 M | $18.93 M |
| 05/13/2025 | Q1 2025 | $0.09 | -$0.06 | -0.15 | $15.14 M | $17.28 M |
| 03/18/2025 | Q4 2024 | -$0.02 | -$0.02 | -0 | $10.53 M | $11.65 M |
| 11/12/2024 | Q3 2024 | $0.00 | $0.02 | 0.02 | $9.70 M | $10.32 M |
| 08/08/2024 | Q2 2024 | -$0.07 | -$0.12 | -0.05 | $8.80 M | $9.07 M |
| 05/09/2024 | Q1 2024 | -$0.07 | -$0.03 | 0.04 | $7.70 M | $7.97 M |
| 03/14/2024 | Q4 2023 | -$0.04 | -$0.09 | -0.05 | $7.70 M | $7.31 M |
| 11/09/2023 | Q3 2023 | -$0.10 | -$0.02 | 0.08 | $6.26 M | $7.03 M |
| 08/10/2023 | Q2 2023 | -$0.09 | $0.18 | 0.27 | $6.50 M | $12.00 M |
| 05/11/2023 | Q1 2023 | -$0.14 | -$0.11 | 0.03 | $4.60 M | $5.30 M |
| 03/16/2023 | Q4 2022 | $0.01 | $0.04 | 0.03 | $9.10 M | $8.50 M |
| 11/10/2022 | Q3 2022 | -$0.15 | -$0.13 | 0.02 | $3.05 M | $3.22 M |
| 08/11/2022 | Q2 2022 | -$0.02 | -$0.06 | -0.05 | $7.80 M | $7.36 M |
| 05/12/2022 | Q1 2022 | -$0.08 | -$0.22 | -0.14 | $7.10 M | $2.18 M |
| 03/16/2022 | Q4 2021 | $0.19 | $0.04 | -0.15 | $7.56 M | $6.09 M |
| 11/16/2021 | Q3 2021 | N/A | -$0.24 | N/A | $3.04 M | $775.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eton Pharmaceuticals Inc Earnings: FAQ's
In the previous quarter, Eton Pharmaceuticals Inc (:ETON) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.1898 by $0.2402.
The conference call for Eton Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Eton Pharmaceuticals Inc's latest earnings report can be read online.
Eton Pharmaceuticals Inc (:ETON) has a recorded annual revenue of $79.95 M.
Eton Pharmaceuticals Inc (:ETON) has a recorded net income of $-4,601,000.Eton Pharmaceuticals Inc has generated $-0.17 earnings per share over the last four quarters.
Eton Pharmaceuticals Inc (:ETON) has a price-to-earnings ratio of 136.49 and price/earnings-to-growth ratio is 0.19.